$DOCU

Docusign (DOCU) announced that its SAP Signature and Agreement Management solutions will be sold as SAP Solution Extensions, integrating Docusign Intelligent Agreement Management (IAM) into SAP Sales Cloud and SAP SuccessFactors. This enables customers to manage contracts within these systems, improving workflow efficiency and data synchronization. The solutions are SAP-branded, sold, and supported, aiming to reduce friction in business processes.

DocuSign's average 12-month price target increased from $71.07 to $71.5, with a range of $60 to $86, implying 15% downside from the Oct. 22 close. Analysts' consensus rating remains 'Hold' with 5 Buys, 16 Holds, and 2 Sells.

Software stocks rose in afternoon trading as investors rotated into high-growth tech from semiconductors, driven by AI sector confidence and macroeconomic concerns. According to CNBC, this shift led to gains in monday.com (MNDY, +6.5%), Adobe (ADBE, +3.2%), DocuSign (DOCU, +3.1%), Intuit (INTU, +3%), and MongoDB (MDB, +3.4%). The article notes monday.com's volatility and recent performance, down 29.9% YTD and 51% below its 52-week high.

Docusign (DOCU) expanded its partnership with Salesforce (CRM), integrating its Intelligent Agreement Management platform into Salesforce, Agentforce, and Slack. The integration allows users to manage agreements within Salesforce's ecosystem, including contract generation, negotiation, and analytics. The companies have partnered for over 20 years.

Netflix (NFLX) was recommended by Stephen Weiss, with Morgan Stanley lowering its price target to $80. AbbVie (ABBV) was picked by Jim Lebenthal, following FDA designations. DocuSign (DOCU) was highlighted by Jenny Harrington, after reporting strong Q2 results with $875.75M revenue and $1.16 EPS.

DocuSign has launched a new application for creating and editing PDFs. The company's stock (DOCU) is currently trading at 70.34 USD, with a 5-day change of +2.10%. Recent news includes an insider share sale and removal from the FTSE All-World Index.

Docusign (DOCU) launched a PDF Editor to streamline document preparation and signing. The tool integrates PDF editing with its Intelligent Agreement Management platform, aiming to reduce manual handoffs. It will be available to IAM and eSignature customers starting November 2, 2026. According to the company, 95% of Fortune 500 businesses use Docusign for eSignature.

Yorkville Ives initiated coverage on Docusign (DOCU) with an In Line rating and a $72 price target, citing AI risks and growth potential. The stock has gained 44% over six months. Analysts highlight Docusign's strong financials, including an 80% gross margin, and recent product releases. Several firms raised their price targets following the company's 9.4% revenue growth in Q2, driven by digital sales and IAM bookings.

Docusign (DOCU) Chief Revenue Officer Paula Hansen sold 3,300 shares on 2026-10-01, retaining 106,557 shares. This follows a trend of 41 insider sells and 0 buys in the past year. The stock trades at $68.81, with a P/E of 41.98, and is considered fairly valued by GuruFocus. Institutional investors are divided, with 3 adding and 5 trimming positions.

DocuSign CRO Paula Hansen sold 3,300 shares of DOCU stock on October 1, 2026, totaling $227,061. The sales were part of a 10b5-1 plan. DOCU shares have risen 43% in six months, trading near a 52-week high. Analysts have mixed price targets, with some seeing undervaluation and others focusing on IAM growth. The company reported strong Q2 revenue growth and raised fiscal 2027 targets.